(Q34295064)

English

Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Silvia Chiesa

4

0 references

Alba Fiorentino

object named as

Alba Fiorentino

2

0 references

Berardino De Bari

object named as

Berardino De Bari

10

0 references

Pasquale De Bonis

object named as

Pasquale De Bonis

3

0 references

Alessio G Morganti

object named as

Alessio Giuseppe Morganti

15

0 references

Stefania Manfrida

object named as

Stefania Manfrida

5

0 references

Gian Carlo Mattiucci

object named as

Gian Carlo Mattiucci

9

0 references

Vincenzo Valentini

17

object named as

Vincenzo Valentini

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Mario Balducci

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Giuseppe Roberto D'Agostino

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Giovanna Mantini

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Vincenzo Frascino

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Annunziato Mangiola

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francesco Miccichè

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Maria Antonietta Gambacorta

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gabriella Colicchio

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Carmelo Anile

16

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

7 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3478-3483

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Increasing annual incidence of primary malignant brain tumors in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Treatment of glioblastoma in "elderly" patients

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Treatment of high-grade gliomas in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Survival analysis part I: basic concepts and first analyses

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Glioma in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

The limited value of cytoreductive surgery in elderly patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Debulking or biopsy of malignant glioma in elderly people - a randomised study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

A prospective study on glioblastoma in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiation therapy in the elderly: more side effects and complications?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Radiotherapy for glioblastoma in the elderly.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0263-3

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-012-0263-3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34295064&oldid=2196472851"